Cearvol Wave vs Lexie B3

The Cearvol Wave is a budget-priced OTC hearing aid with a visible in-ear style, earning a B grade with a SoundScore of 3.9/5 in our lab testing. At $397, it ranks #22 among 65 OTC hearing aids tested, placing it in the top 32% of its category. This device demonstrates notable strengths in music streaming, scoring 4.1/5—a strong result that sits 2.18 points above the OTC category average. Speech performance is solid in quiet environments at 3.1/5, measuring 0.36 points above average. Speech in noise scores 2.0/5, which is above the category average by 0.56 points, though this remains a mixed result in absolute terms. The Cearvol Wave shows some trade-offs in other areas. Own-voice comfort scores 2.1/5, falling 0.41 points below the category average—a consideration for those sensitive to how their own voice sounds while wearing hearing aids. Feedback handling measures 3.8/5, which is solid in absolute terms, though it sits 0.74 points below the typically strong OTC category average for this metric. The Cearvol Wave is best suited for budget-conscious consumers who prioritize music streaming quality and want solid speech clarity in quieter settings. Those who frequently encounter noisy environments or are particularly sensitive to own-voice quality may want to consider alternatives.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.